These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 24848341)

  • 1. Biomaterials for nanoparticle vaccine delivery systems.
    Sahdev P; Ochyl LJ; Moon JJ
    Pharm Res; 2014 Oct; 31(10):2563-82. PubMed ID: 24848341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymeric nanoparticle vaccines to combat emerging and pandemic threats.
    Wibowo D; Jorritsma SHT; Gonzaga ZJ; Evert B; Chen S; Rehm BHA
    Biomaterials; 2021 Jan; 268():120597. PubMed ID: 33360074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides.
    Wilson JT; Keller S; Manganiello MJ; Cheng C; Lee CC; Opara C; Convertine A; Stayton PS
    ACS Nano; 2013 May; 7(5):3912-25. PubMed ID: 23590591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in veterinary vaccine adjuvants.
    Singh M; O'Hagan DT
    Int J Parasitol; 2003 May; 33(5-6):469-78. PubMed ID: 12782048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Directing vaccine immune responses to mucosa by nanosized particulate carriers encapsulating NOD ligands.
    Pavot V; Climent N; Rochereau N; Garcia F; Genin C; Tiraby G; Vernejoul F; Perouzel E; Lioux T; Verrier B; Paul S
    Biomaterials; 2016 Jan; 75():327-339. PubMed ID: 26539801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tailoring nanostructured lipid carriers for the delivery of protein antigens: Physicochemical properties versus immunogenicity studies.
    Courant T; Bayon E; Reynaud-Dougier HL; Villiers C; Menneteau M; Marche PN; Navarro FP
    Biomaterials; 2017 Aug; 136():29-42. PubMed ID: 28511142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles and Vaccine Development.
    Kheirollahpour M; Mehrabi M; Dounighi NM; Mohammadi M; Masoudi A
    Pharm Nanotechnol; 2020; 8(1):6-21. PubMed ID: 31647394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering Strategies for Lymph Node Targeted Immune Activation.
    Chen Y; De Koker S; De Geest BG
    Acc Chem Res; 2020 Oct; 53(10):2055-2067. PubMed ID: 32910636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological Principles Guiding the Rational Design of Particles for Vaccine Delivery.
    Gause KT; Wheatley AK; Cui J; Yan Y; Kent SJ; Caruso F
    ACS Nano; 2017 Jan; 11(1):54-68. PubMed ID: 28075558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogen-like particles: biomimetic vaccine carriers engineered at the nanoscale.
    Rosenthal JA; Chen L; Baker JL; Putnam D; DeLisa MP
    Curr Opin Biotechnol; 2014 Aug; 28():51-8. PubMed ID: 24832075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs.
    Dhakal S; Renu S; Ghimire S; Shaan Lakshmanappa Y; Hogshead BT; Feliciano-Ruiz N; Lu F; HogenEsch H; Krakowka S; Lee CW; Renukaradhya GJ
    Front Immunol; 2018; 9():934. PubMed ID: 29770135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino-Modified Polymer Nanoparticles as Adjuvants to Activate the Complement System and to Improve Vaccine Efficacy in Vivo.
    Pan Y; Qi Y; Shao N; Tadle AC; Huang Y
    Biomacromolecules; 2019 Sep; 20(9):3575-3583. PubMed ID: 31415161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of size on particulate vaccine adjuvants.
    Shah RR; O'Hagan DT; Amiji MM; Brito LA
    Nanomedicine (Lond); 2014 Dec; 9(17):2671-81. PubMed ID: 25529570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orchestrating immune responses: How size, shape and rigidity affect the immunogenicity of particulate vaccines.
    Benne N; van Duijn J; Kuiper J; Jiskoot W; Slütter B
    J Control Release; 2016 Jul; 234():124-34. PubMed ID: 27221070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release.
    Ilyinskii PO; Roy CJ; O'Neil CP; Browning EA; Pittet LA; Altreuter DH; Alexis F; Tonti E; Shi J; Basto PA; Iannacone M; Radovic-Moreno AF; Langer RS; Farokhzad OC; von Andrian UH; Johnston LP; Kishimoto TK
    Vaccine; 2014 May; 32(24):2882-95. PubMed ID: 24593999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanocarriers of antigen proteins for vaccine delivery.
    Lopes Chaves L; Dourado D; Prunache IB; Manuelle Marques da Silva P; Tacyana Dos Santos Lucena G; Cardoso de Souza Z; Muniz Mendes Freire de Moura P; Nunes Bordallo H; Rocha Formiga F; de Souza Rebouças J
    Int J Pharm; 2024 Jun; 659():124162. PubMed ID: 38663646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutral polymer micelle carriers with pH-responsive, endosome-releasing activity modulate antigen trafficking to enhance CD8(+) T cell responses.
    Keller S; Wilson JT; Patilea GI; Kern HB; Convertine AJ; Stayton PS
    J Control Release; 2014 Oct; 191():24-33. PubMed ID: 24698946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses.
    Dowling DJ; Scott EA; Scheid A; Bergelson I; Joshi S; Pietrasanta C; Brightman S; Sanchez-Schmitz G; Van Haren SD; Ninković J; Kats D; Guiducci C; de Titta A; Bonner DK; Hirosue S; Swartz MA; Hubbell JA; Levy O
    J Allergy Clin Immunol; 2017 Nov; 140(5):1339-1350. PubMed ID: 28343701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micro- and nanoparticulates for DNA vaccine delivery.
    Farris E; Brown DM; Ramer-Tait AE; Pannier AK
    Exp Biol Med (Maywood); 2016 May; 241(9):919-29. PubMed ID: 27048557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect of dual targeting vaccine adjuvant with aminated β-glucan and CpG-oligodeoxynucleotides for both humoral and cellular immune responses.
    Jin JW; Tang SQ; Rong MZ; Zhang MQ
    Acta Biomater; 2018 Sep; 78():211-223. PubMed ID: 30098441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.